Livestock Vaccine Innovation Fund

The Livestock Vaccine Innovation Fund (LVIF) supported the development and production of innovative vaccines to improve livestock health and the livelihoods of farmers.

This seven-year, CA$57 million partnership sought to improve the health of livestock and to protect the livelihoods of smallholder farmers.

LVIF addressed livestock health issues by supporting the development, production, and commercialization of innovative vaccines against neglected livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia. Learn more about LVIF projects

Objectives

LVIF brought vaccine researchers, manufacturers, and distributors together to:

  • support innovation and leading-edge research by accelerating the development of new vaccines against neglected livestock diseases;
  • increase the efficacy, marketability, and use of existing livestock vaccines; and
  • foster effective partnerships between vaccine researchers and public and private sector actors to develop, register, commercialize, and deploy livestock vaccines in a more efficient manner.

LVIF adopted a strategic model that intervened at key entry points in the vaccine development, production, and access continuum. The Fund carried out research activities along three broad streams: 

  • cutting-edge vaccine development
  • vaccine improvement and manufacturing
  • vaccine demand, access, and use (divided in three focal areas: women’s empowerment, scaling up, and partnerships) 

Highlights


Researchers in France, Kenya, and Burkina Faso are developing a new combined heartwater-CCPP vaccine that offers broader protection against more strains of heartwater.

Bringing together vaccine researchers, manufacturers and distributors, the Livestock Vaccine Innovation Fund accelerates the discovery of new vaccines and the improvement of existing solutions.

Researchers at Onderstepoort in South Africa are developing a new tissue-culture derived heartwater vaccine that is simple to administer and does not require antibiotics.

Rift Valley fever (RVF) is a viral disease of goats, sheep, cattle, and humans. It is endemic in large parts of Africa, with outbreaks occurring in three to five-year cycles. RVF not only affects the economic and food security of smallholder farmers in Africa, it also poses a serious public health risk.

Explore research projects that we support.

View all projects

Learn more

A goat is vaccinated against peste des petits ruminants in Bawku West District 2
Events
Beyond borders: vaccines, livestock health and global food security in a changing climate
A group of panelist sit on a stage.
Research in Action
Towards climate-resilient agriculture in North Africa
Ugandan women farmers sit in a meeting with researchers.
Research in Action
Research-backed recommendations to improve veterinary vaccine delivery for smallholder farmers
A pair of hands give a vaccination to the neck of a pig.
Research in Action
One Health approach making inroads against neglected disease in Madagascar 
Three young women sit on a bench and read a notepad.
Research in Action
Gender-inclusive training materials to sensitize communities about the benefits of animal vaccines
A woman wearing PPE writes on a piece of paper, a woman looks at a screen, a woman sits holding two children on her lap.
Story
Advancing Southern solutions for gender equality
More than 1,200 vaccination calendars in English, Swahili, and Kinyarwanda have been distributed across East Africa.
Research in Action
Empowering and engaging women in livestock vaccine value chains in East Africa
A Women Rear vaccinator visits a farmer in Ghana.
Research in Action
Women in Ghana achieving equal access to livestock vaccines
Lab assistant Richard Keshura is detecting disease antibodies in a sample at the Kenya Agricultural and Livestock Organization.
Research in Action
How vaccine platforms can help address neglected livestock diseases
View all

Partners

Gates Foundation
Global Affairs Canada

Share this page